Literature DB >> 31829756

An overview of the neuroendocrine system in Parkinson's disease: what is the impact on diagnosis and treatment?

Agata Mulak1.   

Abstract

Introduction: A growing body of evidence indicates that neuroendocrine interactions may occur at all levels of the brain-gut-microbiota axis, which is directly involved in the pathogenesis of Parkinson's disease (PD).Areas covered: The review presents some current and emerging concepts regarding the organization and functioning of the neuroendocrine system as well as the role of neuroendocrine disturbances in the pathophysiology and symptomatology of PD. The concept of the brain-gut-microbiota triad interactions in the neuroendocrine system and PD is proposed. In PD, dysregulation of the main neuroendocrine axes coordinated by the hypothalamus is accompanied by disruptions at the peripheral level, which involve enteroendocrine cells producing numerous neuropeptides. Moreover, the important role of the gut microbiota as a main coordinator of immune and neuroendocrine interactions is discussed. The potential diagnostic and therapeutic implications in the context of the recent developments in the fields of neuroendocrinology and neurodegeneration are also presented.Expert opinion: Unraveling complex neuroendocrine interactions in the course of PD may provide crucial diagnostic implications and novel therapeutic approaches including the application of gut neuropeptides and gut microbiota modification.

Entities:  

Keywords:  Parkinson’s disease; brain-gut axis; enteroendocrine cells; gut microbiota; neuroendocrine system

Mesh:

Year:  2019        PMID: 31829756     DOI: 10.1080/14737175.2020.1701437

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  2 in total

Review 1.  New hope for Parkinson's disease treatment: Targeting gut microbiota.

Authors:  Hong-Xia Fan; Shuo Sheng; Feng Zhang
Journal:  CNS Neurosci Ther       Date:  2022-07-13       Impact factor: 7.035

Review 2.  Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease.

Authors:  Agata Mulak
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.